2,179
Views
4
CrossRef citations to date
0
Altmetric
Articles

Healthcare resource use and reimbursement amount by site of care in patients with diffuse large B-cell lymphoma receiving chimeric antigen receptor T-cell (CAR-T) therapy – a retrospective cohort study using CMS 100% Medicare claims database

, , , , , , & show all
Pages 339-348 | Received 09 Jun 2022, Accepted 29 Oct 2022, Published online: 21 Nov 2022

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Chendi Cui, Chaoling Feng, Ning Rosenthal, Sally W. Wade, Laura Curry, Christine Fu & Gunjan L. Shah. Hospital healthcare resource utilization and costs for chimeric antigen T-cell therapy and autologous hematopoietic cell transplant in patients with large B-cell lymphoma in the United States. Leukemia & Lymphoma 0:0, pages 1-10.
Read now

Articles from other publishers (3)

Jinal M. Mehta, Shivani C. Hiremath, Chishiba Chilimba, Azin Ghasemi & Jessica D. Weaver. (2024) Translation of cell therapies to treat autoimmune disorders. Advanced Drug Delivery Reviews 205, pages 115161.
Crossref
Doris K. Hansen, Yi-Hsuan Liu, Sandip Ranjan, Hitesh Bhandari, Ravi Potluri, Lindsay McFarland, Kevin C. De Braganca & Stephen Huo. (2023) The Impact of Outpatient versus Inpatient Administration of CAR-T Therapies on Clinical, Economic, and Humanistic Outcomes in Patients with Hematological Cancer: A Systematic Literature Review. Cancers 15:24, pages 5746.
Crossref
Gabriela A. Llaurador, Helen E. Heslop & David H. Steffin. (2023) Moving CAR‐Ts to the outpatient clinic . British Journal of Haematology 203:4, pages 507-508.
Crossref